Skip to content

Pharmaceutical Resource & Education Services

Pharmaceutical Resource & Education Services

Advancing Excellence in Sterility Assurance

Menu
  • Home
  • About US
  • Blog
  • Video Library
  • Shopping cart
  • Join US
    • Restricted Access
  • Contact

Tag: Indian Pharmaceutical Industry to support a pandemic crisis with hydroxychloroquine

Growth in BI at Moist Heat Terminal Sterilization

1 Comment
| Drug regulatory and guidelines, Steam Sterilizer, Technology

Terminal sterilization is the reliable process to assure the sterility of the product. Regulators more relay on the Moist heat terminal sterilization process than aseptic processing. In terminal sterilization product sterilized in the final container. Terminal sterilization should be utilized when the product and container/closure system are able to withstand the terminal sterilization process. Note: Kindly […]

Read More »

Defining log reduction based on Product specific bio-burden approach

No Comments
| Industrial Microbiology, Sterility Assurance

When the bioburden method is employed for sterilization process, the bioburden trend of materials and products should be routinely and frequently monitored and, if more heat-resistant microorganisms are identified, then method should re-validate and the potential effect of the microorganisms on pharmaceutical products already shipped from the plant need to be evaluated to ensure patient […]

Read More »

Contributions Indian Pharma Industry to fight against COVID-19

4 Comments
| News Updates

Remdesivir is an experimental drug from drug maker Gilead that has shown to bring down the viral load on patients and hence help in faster discharge. The efficacy of the drug on severe patients is still under study. The drug, intravenously administered in hospitals, has already been approved for emergency use in severely-ill patients in […]

Read More »

Contribution of Indian Pharmaceutical Industry to support a pandemic crisis with hydroxychloroquine

No Comments
| News Updates

Certainly, hydroxychloroquine is in the peak news. Because Mr. President of USA commented in his official Twitter as well as press release also. Other countries also started following the same and looking for the medicine hydroxychloroquine. But let’s see what WHO recommending for this medicine, “1WHO is actively following the ongoing clinical trials that are […]

Read More »

Archives

  • June 2026
  • April 2026
  • March 2026
  • January 2026
  • November 2025
  • October 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • July 2023
  • February 2023
  • November 2022
  • November 2020
  • August 2020
  • July 2020
  • June 2020
  • April 2020
  • January 2020
  • September 2019
  • August 2018
  • March 2018
  • January 2018
  • August 2017
  • July 2017
  • March 2017
  • December 2016
  • November 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • June 2015
  • May 2015
  • February 2015
  • December 2014
  • November 2014
  • September 2014
  • July 2014
  • June 2014
  • May 2014
  • March 2014
  • February 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • May 2013
  • April 2013
  • March 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012

Meta

  • Register
  • Log in

Subsribe To Our Newsletter

Stay in touch with us to get latest news and special offers.

Address

1000, Brussels, Belgium

Email Us

mail2uscgmp@gmail.com

default-logo

Welcome to PRES. We are dedicated to provide technical solutions for sterile injectable business

Our Main Services

  • Mentoring
  • Business Analytics
  • Sterility Assurance
  • Validation Support
  • Audit Compliance

Follow Us

  • Facebook
  • Twitter
  • Youtube
  • Linkedin
Copyright © 2026 Pharmaceutical Resource & Education Services
Powered by Pharmaceutical Resource & Education Services